The overexpression and activation of PI3K-mTOR signaling, including translation pathway components, frequently occurs in HH-driven MB tumors resistant to SMO inhibitors; the crosstalk and interaction between HH and PI3K-mTOR might be a cause of this tumor resistance [22–24]. This evidence concerns the gene MTOR and neoplasm.